IFNgamma sensitization to TRAIL-induced apoptosis in human thyroid carcinoma cells by upregulating Bak expression

Su He Wang1, Emese Mezosi, Julie M Wolf

  • 1Department of Medicine, University of Michigan Medical Center, Ann Arbor, MI, USA.

Oncogene
|December 3, 2003
PubMed

Insights

Combining interferon-gamma (IFNγ) with TRAIL effectively triggers apoptosis in resistant thyroid cancer cells. This combination therapy significantly inhibits tumor growth in vivo, with Bak upregulation identified as a key mechanism.

Area of Science:

  • Oncology
  • Molecular Biology
  • Immunology

Background:

  • TRAIL (TNF-related apoptosis-inducing ligand) induces apoptosis in tumor cells and is a promising cancer treatment.
  • TRAIL spares most normal tissues, distinguishing it from other TNF family members.
  • Thyroid cancer, particularly anaplastic carcinoma, often exhibits resistance to conventional therapies.

Purpose of the Study:

  • To investigate the synergistic effect of interferon-gamma (IFNγ) and TRAIL on resistant thyroid cancer cells.
  • To elucidate the molecular mechanisms underlying IFNγ-sensitized TRAIL-induced apoptosis in thyroid cancer.
  • To evaluate the in vitro and in vivo efficacy of the combined IFNγ and TRAIL therapy.

Main Methods:

  • In vitro apoptosis assays on thyroid anaplastic carcinoma (ARO) cells treated with IFNγ and TRAIL.
  • In vivo mouse thyroid tumor model to assess tumor growth inhibition.
  • Microarray analysis to screen for gene alterations induced by IFNγ.
  • RNase protection assay and Western blot to confirm Bak gene and protein expression.
  • Gene silencing and overexpression studies using antisense Bak to validate its role.

Main Results:

  • IFNγ combined with TRAIL induced significant apoptosis in resistant thyroid cancer cell lines (ARO cells), while single agents had minimal effect.
  • The combination therapy significantly inhibited tumor growth in a mouse thyroid tumor model.
  • Microarray analysis revealed marked upregulation of the proapoptotic gene Bak by IFNγ.
  • Increased Bak expression at both mRNA and protein levels was confirmed, and this was essential for IFNγ-sensitized TRAIL-induced apoptosis.
  • Overexpression of Bak alone sensitized ARO cells to TRAIL-induced apoptosis, bypassing the need for IFNγ.

Conclusions:

  • IFNγ sensitizes resistant thyroid cancer cells to TRAIL-induced apoptosis.
  • Bak is a critical mediator in the IFNγ-facilitated TRAIL-mediated apoptotic pathway in thyroid cancer.
  • The combination of IFNγ and TRAIL, mediated by Bak upregulation, represents a potential therapeutic strategy for thyroid cancer.

Related Concept Videos

NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
Enzyme-linked Receptors01:13

Enzyme-linked Receptors

Enzyme-linked receptors are proteins that act as both receptor and enzyme, activating multiple intracellular signals. This is a large group of receptors that include the receptor tyrosine kinase (RTK) family. Many growth factors and hormones bind to and activate the RTKs.Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
Intracellular Signaling Affects Focal Adhesions01:17

Intracellular Signaling Affects Focal Adhesions

Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...